Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-22

Clinical Trial Update: Glucocorticoids and Skin Healing in Diabetes (GC-SHealD) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating glucocorticoids for skin healing in type 2 diabetes completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Leeds | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED